Trial Profile
Efficacy of once every four week oral minodronate in patients with glucocorticoid-induced osteoporosis after switching from weekly oral bisphosphonate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2020
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 03 Mar 2020 Status changed from active, no longer recruiting to completed.
- 06 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 20 Mar 2014 New trial record